Literature DB >> 36047773

Recessive Mutations in CFAP74 Cause Primary Ciliary Dyskinesia with Normal Ciliary Ultrastructure.

Luisa Biebach1, Sandra Cindrić1, Julia Koenig1, Isabella Aprea1, Gerard W Dougherty1, Johanna Raidt1, Diana Bracht1, Renate Ruppel2, Jens Schreiber3, Rim Hjeij1, Heike Olbrich1, Heymut Omran1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 36047773      PMCID: PMC9447143          DOI: 10.1165/rcmb.2022-0032LE

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   7.748


× No keyword cloud information.
To the Editor: Motile cilia and sperm flagella are specialized hair-like organelles that share a common 9 + 2 microtubule-based axonemal ultrastructure of one central pair (CP) complex surrounded by nine peripheral doublets and numerous associated structures. Although in respiratory epithelial cells the coordinated ciliary beating enables mucociliary clearance of the airways, flagellar beating is essential for sperm cells to propel through the female reproductive tract for reproduction (1). Mutations in numerous ciliary genes can lead to various degrees of ciliary and/or flagellar beating impairment, resulting in different but partially overlapping disease entities referred to as motile ciliopathies. Primary ciliary dyskinesia (PCD) is the hallmark motile ciliopathy, in which impaired mucociliary clearance ultimately leads to chronic destructive airway disease primarily characterized by localized bronchiectasis. Chronic upper respiratory tract symptoms include rhinitis and/or sinusitis and middle ear involvement. Further clinical manifestations of PCD can include situs abnormalities, reduced fertility, and/or rarely hydrocephalus (2). PCD is a rare disease, and various complex diagnostic steps are necessary to confirm the diagnosis. Genetic analysis can identify causative mutations in only about 70% of cases (3). Thus, gene discovery and adequate clinical phenotyping remains important to improve PCD diagnostics. The term “multiple morphological abnormalities of the sperm flagella” (MMAF) was originally proposed for patients with asthenoteratozoospermia lacking any additional PCD specific respiratory symptoms (4). However, this distinction has become less clear. Mutations in SPEF2, which encodes a CP-associated protein, were originally described in males with MMAF but later demonstrated to cause a PCD phenotype (5–7). CP complex associated defects are difficult to identify because affected individuals present no situs abnormalities and show subtle changes in high-speed video microscopy analysis (HSVMA) (7). CFAP74 (cilia and flagella associated protein 74) is the mammalian homolog of FAP74, a subunit of the C1d projection of the central apparatus (Figure E5 in the data supplement) as demonstrated in Chlamydomonas (8). Flagella of FAP74 knockdown Chlamydomonas show abnormal beating patterns with reduced frequencies (9). A recent study reported two patients with biallelic mutations in CFAP74 that cause MMAF. Both patients also suffered from chronic airway disease; therefore, PCD was suspected but not assessed (10). Here, we report three affected individuals from two families with compound heterozygous mutations in CFAP74 and demonstrate abnormal ciliary beating and reduced mucociliary clearance responsible for the PCD phenotype. (Detailed methods description, clinical findings, and results are provided in the data supplement.) Two individuals were identified using a genetic panel that included CFAP74. Subsequently, genetic testing of one symptomatic sister was performed using Sanger sequencing. Three different novel loss-of-function mutations in CFAP74 were identified (Figures 1A and 1B). OP-3882 II1 and OP-3882 II2 are siblings descended from a nonconsanguineous German family. Both were identified with c.907del, p.Gln303LysfsTer65 and c.4380_4381dup, p.Phe1461SerfsTer12 mutations in CFAP74. In OP-4027 II1, the CFAP74 mutation c.4380_4381dup and also the mutation c.1706dup, p.Gly570TrpfsTer10 were identified. Segregation analysis of the parents confirmed compound heterozygosity in all cases. The absence of CFAP74 in CFAP74-mutant respiratory epithelial cells was demonstrated by immunoblot analysis of axonemal extracts using anti-CFAP74 antibodies confirming recessive loss-of-function mutations in OP-3882 II1 and OP-3882 II2 (Figures 1C–1E).
Figure 1.

Compound heterozygous loss-of-function mutations in CFAP74 in OP-3882 II1, OP-3882 II2 and OP-4027 II1 cause PCD. (A) Pedigrees of the two index families are shown. Electropherograms of Sanger sequencing results of CFAP74 amplicons of individuals OP-3882 II1 and OP-3882 II2 demonstrate a heterozygous deletion of one base pair (CFAP74 c.907del) and on the second allele, a duplication of two base pairs (CFAP74 c.4380_4381dup) both predicting a premature termination of translation (p.Gln303LysfsTer65 and p.Phe1461SerfsTer12) (red arrow; amino acids are indicated below nucleotide sequence). The wild-type (WT) sequence is shown in the top row. Individual OP-3882 I1 carries only the duplication in a heterozygous state, confirming segregation. Sequencing chromatograms of CFAP74 amplicons of individuals OP-4027 II1 demonstrate the same duplication of two base pairs (CFAP74 c.4380_4381dup) predicting a premature termination of translation (p.Phe1461SerfsTer12) and an additional heterozygous duplication of one base pair (CFAP74 c.1706dup) resulting in a premature termination of translation (p.Gly570TrpfsTer10 (red arrow; amino acids are indicated below nucleotide sequence). The WT sequence is shown in the top row. The parents OP-4027 I1 and OP-4027 I2 carry only one of the two mutations, respectively, in a heterozygous state, confirming segregation. (B) Schematic presentation of CFAP74 on chromosome 1 is shown along with the transcript diagram. The positions of the identified mutations are indicated by exons highlighted in red. (C–E) Immunoblot analysis demonstrates the absence of the CFAP74 protein (full-length ∼179 kDa isoform, Q9C0B2) in CFAP74-mutant respiratory epithelial cells. Axonemal extracts from CFAP74-mutant and control human primary respiratory epithelial cells were prepared from air–liquid interface (ALI) cultured respiratory cells. (C) Silver staining after lithium dodecyl sulfate-PAGE of normalized amounts of loaded protein (2 µg per sample) demonstrates the integrity of protein recovery from the axonemal preparations. (D) Immunoblot using anti-acetylated-α-tubulin (50 kDa) antibodies also confirmed equal amounts of axonemal proteins. (E) Immunoblot analysis of healthy control axonemal extracts and CFAP74-mutant axonemal extracts was performed with rabbit polyclonal anti-CFAP74 antibodies. Two bands were detectable in axonemal extracts from a healthy control subject. The higher molecular weight band corresponds to the predicted protein size of the large CFAP74 isoform (179 kDa). This band was absent in both CFAP74-mutant axonemal extracts consistent with loss-of function mutations. Only one band at a predicted size around 100 kDa remained detectable, which probably represents unspecific binding or a shorter CFAP74 isoform.

Compound heterozygous loss-of-function mutations in CFAP74 in OP-3882 II1, OP-3882 II2 and OP-4027 II1 cause PCD. (A) Pedigrees of the two index families are shown. Electropherograms of Sanger sequencing results of CFAP74 amplicons of individuals OP-3882 II1 and OP-3882 II2 demonstrate a heterozygous deletion of one base pair (CFAP74 c.907del) and on the second allele, a duplication of two base pairs (CFAP74 c.4380_4381dup) both predicting a premature termination of translation (p.Gln303LysfsTer65 and p.Phe1461SerfsTer12) (red arrow; amino acids are indicated below nucleotide sequence). The wild-type (WT) sequence is shown in the top row. Individual OP-3882 I1 carries only the duplication in a heterozygous state, confirming segregation. Sequencing chromatograms of CFAP74 amplicons of individuals OP-4027 II1 demonstrate the same duplication of two base pairs (CFAP74 c.4380_4381dup) predicting a premature termination of translation (p.Phe1461SerfsTer12) and an additional heterozygous duplication of one base pair (CFAP74 c.1706dup) resulting in a premature termination of translation (p.Gly570TrpfsTer10 (red arrow; amino acids are indicated below nucleotide sequence). The WT sequence is shown in the top row. The parents OP-4027 I1 and OP-4027 I2 carry only one of the two mutations, respectively, in a heterozygous state, confirming segregation. (B) Schematic presentation of CFAP74 on chromosome 1 is shown along with the transcript diagram. The positions of the identified mutations are indicated by exons highlighted in red. (C–E) Immunoblot analysis demonstrates the absence of the CFAP74 protein (full-length ∼179 kDa isoform, Q9C0B2) in CFAP74-mutant respiratory epithelial cells. Axonemal extracts from CFAP74-mutant and control human primary respiratory epithelial cells were prepared from air–liquid interface (ALI) cultured respiratory cells. (C) Silver staining after lithium dodecyl sulfate-PAGE of normalized amounts of loaded protein (2 µg per sample) demonstrates the integrity of protein recovery from the axonemal preparations. (D) Immunoblot using anti-acetylated-α-tubulin (50 kDa) antibodies also confirmed equal amounts of axonemal proteins. (E) Immunoblot analysis of healthy control axonemal extracts and CFAP74-mutant axonemal extracts was performed with rabbit polyclonal anti-CFAP74 antibodies. Two bands were detectable in axonemal extracts from a healthy control subject. The higher molecular weight band corresponds to the predicted protein size of the large CFAP74 isoform (179 kDa). This band was absent in both CFAP74-mutant axonemal extracts consistent with loss-of function mutations. Only one band at a predicted size around 100 kDa remained detectable, which probably represents unspecific binding or a shorter CFAP74 isoform. All three CFAP74-affected individuals have normal situs composition (situs solitus). Medical histories reported recurrent respiratory infections of various degrees since early childhood. Lung function testing gave normal results or minor alterations in all individuals. Exemplary evidence of upper and lower airway disease in form of localized bronchiectasis, polyposis nasi, and pansinusitis is demonstrated in Figures 2A and 2B. Remarkably, nasal NO production rates were in the normal range, well over the currently established cutoff value for PCD diagnosis (11). OP-3882 II1 was diagnosed with oligoasthenospermia, and most sperm cells presented a mosaic of MMAF including short, coiled, bent, absent, or irregular wide flagella (Figure E1).
Figure 2.

CFAP74 mutations lead to chronic airway disease caused by impaired ciliary airway clearance. (A) Computed tomography scans of the lungs show localized bronchiectasis of the left lower lobe (indicated by black arrows) and dystelectasis of the right middle lobe in OP-3882 II1 (white arrowhead). (B) Images of the paranasal sinus of OP-4027 II1 show polyposis consistent with chronic sinusitis (indicated by asterisks). (C) Functional analyses of the ciliary beating of respiratory cells of a healthy control and two CFAP74-mutant individuals. Tracking experiments were performed with fully differentiated respiratory epithelial cells cultured under ALI conditions. Fluorescent beads were added to the apical compartment of the ALI-filter and recorded. Corresponding differential interference contrast videos were taken to record cell morphology and ciliary beating. A highly nondirected particle transport was observed in all analyzed cultures from both CFAP74-mutant individuals. Visualization of the ciliary clearance (particle transport) by means of overlay of the acquired images and direction diagram as vector (heading) and path representation (trajectories). Scale bars, 100 µm. In the vector representation, the direction of each object is represented as a colored arrow, where the length of the arrow corresponds to the respective object velocity. In the path representation, a path corresponds to the real object movements. The length of the paths corresponds to the respective path length.

CFAP74 mutations lead to chronic airway disease caused by impaired ciliary airway clearance. (A) Computed tomography scans of the lungs show localized bronchiectasis of the left lower lobe (indicated by black arrows) and dystelectasis of the right middle lobe in OP-3882 II1 (white arrowhead). (B) Images of the paranasal sinus of OP-4027 II1 show polyposis consistent with chronic sinusitis (indicated by asterisks). (C) Functional analyses of the ciliary beating of respiratory cells of a healthy control and two CFAP74-mutant individuals. Tracking experiments were performed with fully differentiated respiratory epithelial cells cultured under ALI conditions. Fluorescent beads were added to the apical compartment of the ALI-filter and recorded. Corresponding differential interference contrast videos were taken to record cell morphology and ciliary beating. A highly nondirected particle transport was observed in all analyzed cultures from both CFAP74-mutant individuals. Visualization of the ciliary clearance (particle transport) by means of overlay of the acquired images and direction diagram as vector (heading) and path representation (trajectories). Scale bars, 100 µm. In the vector representation, the direction of each object is represented as a colored arrow, where the length of the arrow corresponds to the respective object velocity. In the path representation, a path corresponds to the real object movements. The length of the paths corresponds to the respective path length. Transmission electron microscopy (TEM) of respiratory cilia of two affected subjects proved a regular ciliary ultrastructure (Figure E2). Consistent with this, high-resolution immunofluorescence microscopy of respiratory epithelial cells from all affected showed a normal localization of the outer dynein arms, nexin-dynein regulatory complexes, and the CP-associated protein SPEF2 (Figures E3 and E4). HSVMA of CFAP74-mutant human respiratory epithelial cells showed reduced ciliary beat frequencies (Figure E6). Subtle abnormalities of the ciliary beating pattern (CBP) were identified. CBP was mostly coordinated but showed a slightly reduced beating amplitude with a partially stiff as well as rotatory pattern (Videos E01–E04). Particle transport analyses of air–liquid interface cultured respiratory epithelial cells showed a nondirected transport and a significantly reduced particle transport velocity in both CFAP74-mutant individuals (Figures 2C and E7 and Videos E09–E10). Mutant respiratory epithelial cells were unable to generate a directed fluid flow across the epithelial surface. This finding provides proof of a decreased ciliary clearance capacity consistent with chronic airway disease present in the CFAP74-mutant individuals. In conclusion, we demonstrate that the CP apparatus-associated protein CFAP74 not only plays an important role for sperm architecture and function but is also important for the integrity of ciliary motility in respiratory epithelial cells and for sustaining ciliary clearance in the airways. Mutations of CFAP74 result in defects of the CP, explaining the observed subtle CBP abnormalities. We reported similar subtle beating abnormalities in individuals carrying pathogenic mutations in genes encoding other CP associated proteins such as HYDIN and SPEF2 (7, 12). Like individuals with HYDIN and SPEF2 mutations, all individuals with CFAP74 mutations display no laterality defects, which is consistent with findings in the corresponding mouse models. In all mouse models for CP defects, no situs abnormalities have been reported, but they showed airway disease consistent with PCD (13). The lack of laterality defects in CFAP74 mutations makes it even more difficult to consider an underlying PCD diagnosis. Common diagnostic algorithms might not have detected PCD in the reported patients. Evidence-based guidelines were published by the European Respiratory Society in 2017 and the American Thoracic Society in 2018, respectively (14, 15). Nasal NO measurement is relevant both in the European Respiratory Society and American Thoracic Society PCD diagnostic guidelines (14, 15). Even though it is known that normal nasal NO values cannot rule out PCD diagnosis (16), nasal NO testing is still widely used as a screening tool, leaving the risk of abandoning the diagnostic process prematurely. The same applies to the analysis of ciliary ultrastructure using TEM, where the diagnostic gap is aggravated as normal nasal NO can coincide with normal TEM (16, 17). We found normal NO values and slightly reduced ciliary beat frequencies with subtle beating abnormalities and normal 9 + 2 ultrastructure in the affected individuals. We also checked whether the axonemal localization of the CP-associated protein SPEF2 is altered in CFAP74-mutant respiratory cilia (Figure E4). However, we found no abnormalities, which is probably explained by the localization of SPEF2 to the C1b projection and CFAP74 to the C1d projection, respectively (Figure E5). Thus, without genetic testing and additional assays such as HSVMA and particle transport analyses, establishing a PCD diagnosis in such cases is challenging. Taken together, we demonstrate that pathogenic mutations in CFAP74 cause PCD with normal situs and contribute to the genetic and clinical diagnosis of PCD with normal nasal NO production rates, normal ciliary ultrastructure, and subtle ciliary beating defects. This highlights the importance of genetic testing as well as establishing new functional analyses like particle-tracking experiments (Figure 2C) in the diagnostic process (18). We conclude that regular screening for CFAP74 mutations should be included for the genetic workup of individuals suspected to suffer from PCD. This study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the Westphalian Wilhelms University of Muenster (2015-104-f-S). Informed consent was obtained from all subjects involved in the study.
  18 in total

1.  Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia.

Authors:  Margaret W Leigh; Milan J Hazucha; Kunal K Chawla; Brock R Baker; Adam J Shapiro; David E Brown; Lisa M Lavange; Bethany J Horton; Bahjat Qaqish; Johnny L Carson; Stephanie D Davis; Sharon D Dell; Thomas W Ferkol; Jeffrey J Atkinson; Kenneth N Olivier; Scott D Sagel; Margaret Rosenfeld; Carlos Milla; Hye-Seung Lee; Jeffrey Krischer; Maimoona A Zariwala; Michael R Knowles
Journal:  Ann Am Thorac Soc       Date:  2013-12

2.  Loss-of-function mutations in SPEF2 cause multiple morphological abnormalities of the sperm flagella (MMAF).

Authors:  Wensheng Liu; Yanwei Sha; Yang Li; Libin Mei; Shaobin Lin; Xianjing Huang; Jinhua Lu; Lu Ding; Shuangbo Kong; Zhongxian Lu
Journal:  J Med Genet       Date:  2019-05-31       Impact factor: 6.318

Review 3.  Value of transmission electron microscopy for primary ciliary dyskinesia diagnosis in the era of molecular medicine: Genetic defects with normal and non-diagnostic ciliary ultrastructure.

Authors:  Adam J Shapiro; Margaret W Leigh
Journal:  Ultrastruct Pathol       Date:  2017-09-15       Impact factor: 1.094

Review 4.  Advances in the Genetics of Primary Ciliary Dyskinesia: Clinical Implications.

Authors:  Amjad Horani; Thomas W Ferkol
Journal:  Chest       Date:  2018-05-22       Impact factor: 9.410

5.  Loss of SPEF2 function in mice results in spermatogenesis defects and primary ciliary dyskinesia.

Authors:  Anu Sironen; Noora Kotaja; Howard Mulhern; Todd A Wyatt; Joseph H Sisson; Jacqueline A Pavlik; Mari Miiluniemi; Mark D Fleming; Lance Lee
Journal:  Biol Reprod       Date:  2011-06-29       Impact factor: 4.285

6.  Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Adam J Shapiro; Stephanie D Davis; Deepika Polineni; Michele Manion; Margaret Rosenfeld; Sharon D Dell; Mark A Chilvers; Thomas W Ferkol; Maimoona A Zariwala; Scott D Sagel; Maureen Josephson; Lucy Morgan; Ozge Yilmaz; Kenneth N Olivier; Carlos Milla; Jessica E Pittman; M Leigh Anne Daniels; Marcus Herbert Jones; Ibrahim A Janahi; Stephanie M Ware; Sam J Daniel; Matthew L Cooper; Lawrence M Nogee; Billy Anton; Tori Eastvold; Lynn Ehrne; Elena Guadagno; Michael R Knowles; Margaret W Leigh; Valery Lavergne
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

7.  Novel mutations in SPEF2 causing different defects between flagella and cilia bridge: the phenotypic link between MMAF and PCD.

Authors:  Chaofeng Tu; Hongchuan Nie; Lanlan Meng; Weili Wang; Haiyu Li; Shimin Yuan; Dehua Cheng; Wenbin He; Gang Liu; Juan Du; Fei Gong; Guangxiu Lu; Ge Lin; Qianjun Zhang; Yue-Qiu Tan
Journal:  Hum Genet       Date:  2020-01-16       Impact factor: 4.132

8.  European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia.

Authors:  Jane S Lucas; Angelo Barbato; Samuel A Collins; Myrofora Goutaki; Laura Behan; Daan Caudri; Sharon Dell; Ernst Eber; Estelle Escudier; Robert A Hirst; Claire Hogg; Mark Jorissen; Philipp Latzin; Marie Legendre; Margaret W Leigh; Fabio Midulla; Kim G Nielsen; Heymut Omran; Jean-Francois Papon; Petr Pohunek; Beatrice Redfern; David Rigau; Bernhard Rindlisbacher; Francesca Santamaria; Amelia Shoemark; Deborah Snijders; Thomy Tonia; Andrea Titieni; Woolf T Walker; Claudius Werner; Andrew Bush; Claudia E Kuehni
Journal:  Eur Respir J       Date:  2017-01-04       Impact factor: 16.671

9.  Limitations of Nasal Nitric Oxide Testing in Primary Ciliary Dyskinesia.

Authors:  Adam J Shapiro; Stephanie D Davis; Margaret W Leigh; Michael R Knowles; Valery Lavergne; Thomas Ferkol
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405

Review 10.  Central Apparatus, the Molecular Kickstarter of Ciliary and Flagellar Nanomachines.

Authors:  Zuzanna Samsel; Justyna Sekretarska; Anna Osinka; Dorota Wloga; Ewa Joachimiak
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.